Every clinical trial presents unique challenges that can lead to costly delays. Sometimes those challenges are so great you need to make the decision to migrate your study to a new EDC platform, such as:

• Complex studies & protocol amendments
• Selling or acquiring a compound
• Changing CRO relationships / changing personnel
• Limited oversight & control of your trial
• The need to consolidate technology into a single platform

No matter the reason for changing your technology and processes mid-study, when you recognize the need to migrate your study, finding the right team of experts to manage the process is critical to ensuring success.

Our Professional Services team understands how to migrate studies and has the experience to overcome the challenges inherent to this complex undertaking. Utilizing a service delivery model of people, process and technology, our experts have rescued studies across all therapeutic areas, from small to large studies in every phase, and from many different types of EDC systems. 

Read how Ambit Biosciences successfully migrated 3 critical oncology studies while still meeting their timelines after dissolving a partnership with a larger pharmaceutical company. Download the Case Study now.